SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Incannex Healthcare, Inc. is a biotech company, which engages in developing cannabinoid and psychedelic compound medicines. It focuses on the research and development for medicinal cannabis pharmaceutical products and psychedelic medicine therapies for treatment of a range of indications. The company was founded on April 27, 2001 and is headquartered in Norwest, Australia.

Incannex Healthcare Inc

Incannex Healthcare Limited - ADR

Incannex Healthcare is trending as it approaches Nasdaq compliance following its recent reverse split, a key de-risking event that has ignited community discussion around its low float. Investors are eagerly anticipating imminent FDA End-of-Phase 2 feedback for its promising IHL-42X sleep apnea drug, fueling speculation of a potential short squeeze and significant upside.

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.

Alpha Tau Medical Ltd

ALPHA TAU MEDICAL LTD

Alpha Tau Medical is trending after securing Japanese marketing approval for its groundbreaking Alpha DaRT technology, which the community views as a significant global validation and de-risking event. This, alongside strong financial reports and imminent clinical trial readouts, is fueling widespread bullish sentiment and discussions of its undervaluation and substantial upside potential.

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath is actively discussed following its first GAAP profitable quarter, strong Q4 performance, and a new $500M stock buyback, with bulls optimistic about its Agentic AI direction and potential government contracts, while others express concern over conservative revenue guidance.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

Escalating Middle East tensions and reported attacks on oil tankers near the Strait of Hormuz are driving a sharp rise in crude oil prices, as the community debates whether strategic reserve releases can effectively counter the ongoing supply risks.

Ondas, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Inc.

Ondas Inc

Ondas is trending due to its aggressive expansion into defense technology with recent strategic acquisitions, including BIRD Aerosystems for missile protection and a merger with Mistral Inc., complemented by new multi-million dollar counter-drone system orders. The market is keenly watching whether these moves will catalyze significant revenue growth and a short squeeze, or if ongoing share dilution will continue to temper price action.

Abivax SA engages in the sale, research, distribution, and development of biopharmaceutical products. It offers commercial and development products of anti-viral compounds and human vaccines. The commercialized products include vaccines for typhoid fever, meningococcus, and leptospirosis. The products under development include vaccines for chronic hepatitis B, ebola, and dengue virus. The company was founded by Philippe Pouletty on December 4, 2003 and is headquartered in Paris, France.

Abivax - ADR

Abivax is trending due to persistent acquisition rumors from major pharmaceutical companies like Eli Lilly and AstraZeneca, fueled by reports from a reputable French publication, highlighting its promising ulcerative colitis treatment and robust clinical data. The community is actively discussing a potential bidding war given the drug's innovative profile and upcoming data presentations, positioning it as a highly attractive target in the biotech sector.

Smart Lending AI (SLAI) is a decentralized on-chain lending protocol that lets users lock approved tokens and instantly borrow up to 50% of their USD value in ETH—without selling. Prices are calculated directly on-chain via WETH pairs, and loan risk is managed through real-time volatility and liquidity analysis. Borrowers pay a flat 5% interest, while SLAI stakers (≥50,000 tokens) enjoy zero interest benefits. Designed for active DeFi traders, SLAI enables fast, gas-efficient liquidity access while preserving token exposure.

Smart Lending AI

Smart Lending AI (SLAI) is trending after receiving a preliminary going-private proposal offering a premium over its recent trading prices, sparking community debate over a potential low-ball buyout and a significant shift in voting power to its founder. This is compounded by discussions around a strategic pivot into AI and blockchain, adding to investor interest.

Chevron Corp. engages in the provision of oil and gas energy solutions. It provides crude oil and natural gas, manufactures transportation fuels, lubricants, petrochemicals, and additives, and develops technologies that enhance business and the industry. It operates through the Upstream and Downstream segments. The Upstream segment consists of the exploration, development, and production of crude oil and natural gas, the liquefaction, transportation, and regasification associated with liquefied natural gas, the transporting of crude oil by major international oil export pipelines, the processing, transporting, storage, and marketing of natural gas, and a gas-to-liquids plant. The Downstream segment consists of the refining of crude oil into petroleum products, the marketing of crude oil and refined products, the transporting of crude oil and refined products by pipeline, marine vessel, motor equipment, and rail car, and the manufacturing and marketing of commodity petrochemicals and plastics for industrial uses and fuel & lubricant additives. The company was founded on September 10, 1879 and is headquartered in Houston, TX.

Chevron Corp.

Escalating geopolitical tensions in the Middle East, including disruptions in the Strait of Hormuz and attacks on oil infrastructure, are propelling crude prices higher, making Chevron a key focus as the community debates its "war premium" and significant long-term expansion opportunities in Venezuela.

ProFrac Holding Corp. engages in the provision of hydraulic fracturing, proppant production, and other completion services. It operates through the following segments: Stimulation Services, Proppant Production, Manufacturing, and Other. The Stimulation Services segment owns a fleet of mobile hydraulic fracturing units and other auxiliary equipment that generates revenue by providing stimulation services to customers. The Proppant Production segment focuses on the provision of proppant to oilfield service providers and exploration and production companies. The Manufacturing segment is involved in the sale of products such as horsepower pumps, valves, piping, swivels, large-bore manifold systems, and fluid ends. The Other segment refers to Flotek Industries and Livewire Power, LLC. The company was founded in 2016 and is headquartered in Willow Park, TX.

ProFrac Holding Corp - Ordinary Shares - Class A

PROFRAC HOLDING CORP

ProFrac Holding Corp (ACDC) is trending following its Q4 2025 earnings report, which delivered a revenue beat against analyst estimates but also a GAAP EPS decline and a softer Q1 2026 outlook due to weather disruptions. The community is actively debating if the revenue upside can offset profitability concerns and previous underperformance, especially given its position in the volatile oilfield services sector.

Dollar General Corp. engages in the operation of merchandise stores. Its offerings include food, snacks, health and beauty aids, cleaning supplies, basic apparel, housewares, and seasonal items. It sells brands including Clorox, Energizer, Procter & Gamble, Hanes, Coca-Cola, Mars, Unilever, Nestle, Kimberly-Clark, Kellogg's, General Mills, and PepsiCo. The company was founded by J. L. Turner and Hurley Calister Turner Sr. in 1939 and is headquartered in Goodlettsville, TN.

Dollar General Corp.

Dollar General is a trending topic as investors grapple with its stock movement following a quarterly earnings beat, sparking community discussion on why shares declined despite strong results and how its value-driven model performs amid evolving consumer habits and operational adjustments.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

LENZ Therapeutics (LENZ) Projected to Post Earnings on Wednesday

LENZ Therapeutics (NASDAQ:LENZ) will be releasing its Q4 2025 earnings before the market opens on Wednesday, March 18. (View Earnings Report at...

Tyro Capital Management LLC Makes New $4.69 Million Investment in LENZ Therapeutics, Inc. $LENZ

Tyro Capital Management LLC bought a new stake in shares of LENZ Therapeutics, Inc. (NASDAQ:LENZ - Free Report) in the 3rd quarter, according to the company in its most recent 13F filing with the...

LENZ Therapeutics, Inc. (NASDAQ:LENZ) Given Average Rating of "Moderate Buy" by Brokerages

LENZ Therapeutics, Inc. (NASDAQ:LENZ - Get Free Report) has been assigned a consensus rating of "Moderate Buy" from the seven ratings firms that are covering the company, Marketbeat.com reports. One...

LENZ Therapeutics (NASDAQ:LENZ) Upgraded by Wall Street Zen to Hold Rating

Wall Street Zen upgraded LENZ Therapeutics from a "sell" rating to a "hold" rating in a research note on Sunday...

Versant Venture Management LLC Buys Shares of 2,656,888 LENZ Therapeutics, Inc. $LENZ

Versant Venture Management LLC purchased a new position in shares of LENZ Therapeutics, Inc. (NASDAQ:LENZ - Free Report) during the 3rd quarter, according to its most recent disclosure with the...

LENZ Therapeutics (NASDAQ:LENZ) Rating Lowered to Sell at Wall Street Zen

Wall Street Zen lowered LENZ Therapeutics from a "hold" rating to a "sell" rating in a research report on Saturday...

LENZ Therapeutics, Inc. $LENZ Shares Acquired by Skandinaviska Enskilda Banken AB publ

Skandinaviska Enskilda Banken AB publ lifted its stake in shares of LENZ Therapeutics, Inc. (NASDAQ:LENZ - Free Report) by 99.0% in the 3rd quarter, according to its most recent Form 13F filing with...

Short Interest in LENZ Therapeutics, Inc. (NASDAQ:LENZ) Decreases By 16.8%

LENZ Therapeutics, Inc. (NASDAQ:LENZ - Get Free Report) was the target of a significant decrease in short interest in the month of January. As of January 30th, there was short interest totaling...

Shares of LENZ Therapeutics, Inc. (NASDAQ:LENZ - Get Free Report) have been assigned an average recommendation of "Moderate Buy" from the seven ratings firms that are presently covering the firm...

New FDA-Approved Eye Drop Sparks Fresh Competition For LENZ Therapeutics' Drug

FDA approved Tenpoint's Yuvezzi eye drop for presbyopia, adding competition for LENZ's VIZZ as analysts say the recent stock drop may be overdone and see blockbuster potential ahead.read more...

LENZ Therapeutics, Inc. is a pre-commercial biopharmaceutical company, which focuses on the development and commercialization of innovative therapies to improve vision. It offers eye drop product treatment for presbyopia. The company was founded by James W. McCollum in July 2013 and is headquartered in Solana Beach, CA.

LENZ
LENZ Therapeutics Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest LENZ News

LENZLENZ Therapeutics Inc.